期刊文献+

MiR-29a通过调节HuR影响前列腺癌细胞的生物学行为 被引量:2

MiR-29a affects the biological behavior by regulating HuR in prostate cancer cells
原文传递
导出
摘要 目的 研究前列腺癌中miR-29a对HuR表达的调节,进而影响细胞增殖、迁移、侵袭、凋亡.方法 通过实时荧光定量(qRT-PCR)和免疫印迹法(Western blot)检测在正常前列腺上皮细胞RWPE-1和激素非依赖性前列腺癌细胞PC-3内miR-29a、人抗原R(HuR) mRNA和蛋白的表达水平;miR-29a mimics(模拟剂)、inhibitor(抑制剂)和NCmiRNA(对照剂)转染PC-3细胞48h后检测miR-29a、HuR mRNA和蛋白的表达水平.细胞增殖试剂盒(CCK-8)、迁移和侵袭实验(Transwell小室)、流式细胞术分别检测PC-3细胞被转染后细胞增殖、迁移侵袭、凋亡的改变.结果 与RWPE-1细胞相比,PC-3细胞中miR-29a的表达下调,HuR mRNA和蛋白的上升(P<0.05).与对照组相比,miR-29a mimics(模拟剂)、inhibitor(抑制剂)转染PC-3细胞后HuR mRNA无改变,但是能够改变HuR蛋白的表达(P<0.05).MiR-29a能够抑制细胞增殖、迁移、侵袭,促进细胞凋亡(P<0.05).结论 在前列腺癌PC-3细胞中,miR-29a通过调节HuR蛋白的表达,进而对细胞增殖、迁移、侵袭、凋亡产生影响. Objective To investigate regulation of human antigens R (HuR) by miR-29a in prostate cancer and affect cell proliferation,migration,invasion and apoptosis.Methods The expression levels of miR-29a,HuR mRNA and protein between normal prostate epithelial RWPE-1 cells and hormone independent prostate cancer PC-3 cells were detected by qRT-PCR and Western blot.The expressions of miR-29a,HuR mRNA and protein were detected again after transfected with miR-29a mimics,inhibitor and negative control(NC) of PC-3 cells for 48 h.The cell proliferation kit (CCK-8),migration and invasion assay (Transwell chamber) and Flow Cytometry were used to detect the change of PC-3 cells on proliferation,migration,invasion and apoptosis after transfection.Results Compared with RWPE-1 cells,miR-29a expression was down-regulated and HuR mRNA and protein were up-regulated in PC-3 cells(P <0.05).Compared with NC,there was no change in HuR mRNA expression,but HuR protein was changed after transfected with miR-29a mimics or inhibitor (P <0.05).MiR-29a had the function of inhibit cell proliferation,migration and invasion,and promote apoptosis(P <0.05).Conclusions MiR-29a regulates the expression of HuR protein in PC-3 cells,which may affect cell proliferation,migration,invasion and apoptosis.
作者 吴硕 辛士永 李亮亮 徐自然 张鹏 张建国 Wu Shuo;Xin Shiyong;Li Liangliang(Department of Urology,College of Clinical Medicine of Henan University of Science and Technology,Luoyang 471003,China)
出处 《国际泌尿系统杂志》 2018年第6期885-889,共5页 International Journal of Urology and Nephrology
基金 洛阳市青年医学科技创新联合专项资金项目(150403)
关键词 前列腺肿瘤 微RNAS 抗原 Prostatic Neoplasms MicroRNAs Antigens
  • 相关文献

参考文献6

二级参考文献104

  • 1刘慧玲,高雪芹.HuR RNA结合蛋白的功能及其与肿瘤关系的研究进展[J].山东医药,2006,46(17):92-93. 被引量:1
  • 2Katso R. Cellular function of phosphoinositide 3 - kinases: implications for development, homestasis and cancer. Annu Rev Cell Dev Biol. 2001,17:612 -675.
  • 3Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human magllgnancy. Cell Signal. 2002, 14 (5) :381 - 395.
  • 4Wen Y, Hu MC, Makino K, et al. HER/neu promotes androgenindependent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 2000, 60(24) : 6841 -6845.
  • 5Zhou G, Hashimoto Y, Kwak 1, et al. Role of the steroid receptor coactivator SRC -3 in cell growth. Mol Cell Biol. 2003, 23(21 ) :7742 - 7755.
  • 6Gioeli D, Ficarro SB, Kwiek JJ, et al. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem,2002,277(32) : 29304-29314 .
  • 7Ihle NT, Williams R, Chow S, et al. Molecular pharmacology and antitumor activity of PX - 866, a novel inhibitor of phosphoinositide - 3 -kinase signaling. Mol Cancer Ther,2004, 3(7) :763 -772.
  • 8Shin - iehi Yaguchi, Yasuhisa Fukui, lchiro Koshimizu, et al. Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3 - Kinase Inhibitor. J Natl Cancer Inst. 2006, 98 (8) : 545 - 556.
  • 9Geng L, Tan J, Himmelfarb E, et al. A specific antagonist of the p110 delta catalytic component of the phosphatidylinositol 3 '- kinase,IC486068, enhances radiaton - induced tumor vascular destruction. Cancer Res. 2004, 64(21 ) : 4893 -4899.
  • 10Fan QW, Knight ZA, Goldenberg DD, et al. A dual P13 kinase/ mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell. 2006, 9(5) :341 -349.

共引文献12

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部